Water Island Capital LLC Revance Therapeutics, Inc. Transaction History
Water Island Capital LLC
- $746 Million
- Q4 2024
A detailed history of Water Island Capital LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Water Island Capital LLC holds 722,234 shares of RVNC stock, worth $1.86 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
722,234
Previous 2,381,196
69.67%
Holding current value
$1.86 Million
Previous $6.12 Million
69.67%
% of portfolio
0.25%
Previous 0.67%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
212Shares Held
78.8MCall Options Held
816KPut Options Held
882K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I05.1MShares$13.1 Million0.78% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY3.5MShares$8.99 Million0.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...